Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Site × apalutamide × 90 days × Clear all

Sponsor

Conditions

Prostatic Neoplasms 33 Stage II Prostate Adenocarcinoma 1 Salivary Gland Neoplasms 1 Non-Muscle Invasive Bladder Urothelial Carcinoma 1 Neoplasm Metastasis 1 Metastatic Hormone-sensitive Prostate Cancer 1 Metastatic Castration-resistant Prostate Neoplasms 1 Metastatic Castrate-sensitive Prostate Cancer 1 Castration Levels of Testosterone 1 Adenocarcinoma 1

Interventions

durvalumab 3 Fulvestrant 3 Cisplatin 3 Carboplatin 3 ribociclib 2 pembrolizumab 2 palbociclib 2 abemaciclib 2 Pemetrexed 2 Letrozole 2 Anastrozole 2 trametinib 1 taletrectinib 1 sotorasib 1 selpercatinib 1 relatlimab 1 pralsetinib 1 exemestane 1 elacestrant 1 darolutamide 1 dabrafenib 1 ceralasertib 1 Watchful Waiting 1 Transurethral Resection of Prostate 1 Sunitinib 1 STX-478 1 Radiotherapy, Intensity-Modulated 1 Radiosurgery 1 RAD1901 1 Pregnancy Tests 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡